Randomized controlled trials in neurosurgery—how good are we?

Summary Background The strongest evidence in medical clinical literature is represented by randomized controlled trials (RCTs). This study was designed to evaluate neurosurgically relevant RCTs published recently by neurosurgeons. Method A literature search in MEDLINE and EMBASE included all clinica...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Acta neurochirurgica 2009-05, Vol.151 (5), p.519-527
Hauptverfasser: Schöller, K., Licht, S., Tonn, J.-C., Uhl, E.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 527
container_issue 5
container_start_page 519
container_title Acta neurochirurgica
container_volume 151
creator Schöller, K.
Licht, S.
Tonn, J.-C.
Uhl, E.
description Summary Background The strongest evidence in medical clinical literature is represented by randomized controlled trials (RCTs). This study was designed to evaluate neurosurgically relevant RCTs published recently by neurosurgeons. Method A literature search in MEDLINE and EMBASE included all clinical studies published up to 30 June 2006. RCTs with neurosurgical relevance published by at least one author with affiliation to a neurosurgical department were selected. The number and characteristics of individual trials were recorded, and the quality of the trials with regard to study design, quality of reporting, and relevance for clinical practice was assessed by two different investigators using a modification of the Scottish Intercollegiate Guidelines Network methodology checklist. Changes of RCT quality over time as well as factors influencing the quality were analyzed. Findings From the initial search results (MEDLINE n = 3,860, EMBASE n = 3,113 articles), 159 RCTs published by neurosurgeons were extracted for final evaluation. Of the RCTs, 62% have been published since 1995; 52% came from the USA, UK, and Germany. The median RCT sample size was 78 patients and the median follow-up 35.7 weeks. Fifty-two percent of all RCTs were of good, 37% of moderate, and 11% of bad quality, with an improvement over time. RCTs with financial funding and RCTs with a sample size of >78 patients were of significantly better quality. There were no major differences in the rating of the studies between the two investigators. Conclusions Only a fraction of neurosurgically relevant literature consists of RCTs, but the quality is satisfying and has significantly improved over the last years. An adequate sample size and sufficient financial support seem to be of substantial importance with regard to the quality of the study. Our data also show that by using a standardized checklist, the quality of trials can be reliably assessed by observers of different experience and educational levels.
doi_str_mv 10.1007/s00701-009-0280-y
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_754555370</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>754555370</sourcerecordid><originalsourceid>FETCH-LOGICAL-c467t-a490cb5254ddaa1e50af51506c5a13e3e9bb34159a8108466740ef35a66c8ac03</originalsourceid><addsrcrecordid>eNp9kc1Kw0AUhQdRbK0-gBsJLnQVvfObZFWk-AcFQXQ9TJJJTUkzdaah1JUP4RP6JN7SQkHQzZ073O-eYc4h5JTCFQVIrgMWoDFAFgNLIV7tkT5kgsVYYB97wKliKu2RoxCmeGOJ4IekRzPOE5WKPhk-m7Z0s_rDllHh2oV3TYPtwtemCVHdRq3tvAudn1i_-v78enPLaOJcGRlvo6UdHpODCkl7sj0H5PXu9mX0EI-f7h9HN-O4ECpZxEZkUOSSSVGWxlArwVSSSlCFNJRbbrM854LKzKQUUqFUIsBWXBqlitQUwAfkcqM79-69s2GhZ3UobNOY1rou6EQKKSVP1uTFv6RKGOWUMgTPf4FT1_kWf6EZR-syBilCdAMV6ELwttJzX8-MX2kKeh2C3oSgkdfrEPQKd862wl0-s-VuY-s6AmwDBBy16Ozu5b9VfwDfEpG-</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>230009208</pqid></control><display><type>article</type><title>Randomized controlled trials in neurosurgery—how good are we?</title><source>MEDLINE</source><source>SpringerLink Journals - AutoHoldings</source><creator>Schöller, K. ; Licht, S. ; Tonn, J.-C. ; Uhl, E.</creator><creatorcontrib>Schöller, K. ; Licht, S. ; Tonn, J.-C. ; Uhl, E.</creatorcontrib><description>Summary Background The strongest evidence in medical clinical literature is represented by randomized controlled trials (RCTs). This study was designed to evaluate neurosurgically relevant RCTs published recently by neurosurgeons. Method A literature search in MEDLINE and EMBASE included all clinical studies published up to 30 June 2006. RCTs with neurosurgical relevance published by at least one author with affiliation to a neurosurgical department were selected. The number and characteristics of individual trials were recorded, and the quality of the trials with regard to study design, quality of reporting, and relevance for clinical practice was assessed by two different investigators using a modification of the Scottish Intercollegiate Guidelines Network methodology checklist. Changes of RCT quality over time as well as factors influencing the quality were analyzed. Findings From the initial search results (MEDLINE n = 3,860, EMBASE n = 3,113 articles), 159 RCTs published by neurosurgeons were extracted for final evaluation. Of the RCTs, 62% have been published since 1995; 52% came from the USA, UK, and Germany. The median RCT sample size was 78 patients and the median follow-up 35.7 weeks. Fifty-two percent of all RCTs were of good, 37% of moderate, and 11% of bad quality, with an improvement over time. RCTs with financial funding and RCTs with a sample size of &gt;78 patients were of significantly better quality. There were no major differences in the rating of the studies between the two investigators. Conclusions Only a fraction of neurosurgically relevant literature consists of RCTs, but the quality is satisfying and has significantly improved over the last years. An adequate sample size and sufficient financial support seem to be of substantial importance with regard to the quality of the study. Our data also show that by using a standardized checklist, the quality of trials can be reliably assessed by observers of different experience and educational levels.</description><identifier>ISSN: 0001-6268</identifier><identifier>EISSN: 0942-0940</identifier><identifier>DOI: 10.1007/s00701-009-0280-y</identifier><identifier>PMID: 19337684</identifier><language>eng</language><publisher>Vienna: Springer Vienna</publisher><subject>Evidence-Based Medicine ; Humans ; Interventional Radiology ; Medicine ; Medicine &amp; Public Health ; Minimally Invasive Surgery ; Neurology ; Neuroradiology ; Neurosurgery ; Neurosurgery - methods ; Neurosurgical Concepts ; Quality Control ; Randomized Controlled Trials as Topic - classification ; Randomized Controlled Trials as Topic - standards ; Research Design ; Surgical Orthopedics</subject><ispartof>Acta neurochirurgica, 2009-05, Vol.151 (5), p.519-527</ispartof><rights>Springer-Verlag 2009</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c467t-a490cb5254ddaa1e50af51506c5a13e3e9bb34159a8108466740ef35a66c8ac03</citedby><cites>FETCH-LOGICAL-c467t-a490cb5254ddaa1e50af51506c5a13e3e9bb34159a8108466740ef35a66c8ac03</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00701-009-0280-y$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00701-009-0280-y$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,778,782,27907,27908,41471,42540,51302</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19337684$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schöller, K.</creatorcontrib><creatorcontrib>Licht, S.</creatorcontrib><creatorcontrib>Tonn, J.-C.</creatorcontrib><creatorcontrib>Uhl, E.</creatorcontrib><title>Randomized controlled trials in neurosurgery—how good are we?</title><title>Acta neurochirurgica</title><addtitle>Acta Neurochir</addtitle><addtitle>Acta Neurochir (Wien)</addtitle><description>Summary Background The strongest evidence in medical clinical literature is represented by randomized controlled trials (RCTs). This study was designed to evaluate neurosurgically relevant RCTs published recently by neurosurgeons. Method A literature search in MEDLINE and EMBASE included all clinical studies published up to 30 June 2006. RCTs with neurosurgical relevance published by at least one author with affiliation to a neurosurgical department were selected. The number and characteristics of individual trials were recorded, and the quality of the trials with regard to study design, quality of reporting, and relevance for clinical practice was assessed by two different investigators using a modification of the Scottish Intercollegiate Guidelines Network methodology checklist. Changes of RCT quality over time as well as factors influencing the quality were analyzed. Findings From the initial search results (MEDLINE n = 3,860, EMBASE n = 3,113 articles), 159 RCTs published by neurosurgeons were extracted for final evaluation. Of the RCTs, 62% have been published since 1995; 52% came from the USA, UK, and Germany. The median RCT sample size was 78 patients and the median follow-up 35.7 weeks. Fifty-two percent of all RCTs were of good, 37% of moderate, and 11% of bad quality, with an improvement over time. RCTs with financial funding and RCTs with a sample size of &gt;78 patients were of significantly better quality. There were no major differences in the rating of the studies between the two investigators. Conclusions Only a fraction of neurosurgically relevant literature consists of RCTs, but the quality is satisfying and has significantly improved over the last years. An adequate sample size and sufficient financial support seem to be of substantial importance with regard to the quality of the study. Our data also show that by using a standardized checklist, the quality of trials can be reliably assessed by observers of different experience and educational levels.</description><subject>Evidence-Based Medicine</subject><subject>Humans</subject><subject>Interventional Radiology</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Minimally Invasive Surgery</subject><subject>Neurology</subject><subject>Neuroradiology</subject><subject>Neurosurgery</subject><subject>Neurosurgery - methods</subject><subject>Neurosurgical Concepts</subject><subject>Quality Control</subject><subject>Randomized Controlled Trials as Topic - classification</subject><subject>Randomized Controlled Trials as Topic - standards</subject><subject>Research Design</subject><subject>Surgical Orthopedics</subject><issn>0001-6268</issn><issn>0942-0940</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kc1Kw0AUhQdRbK0-gBsJLnQVvfObZFWk-AcFQXQ9TJJJTUkzdaah1JUP4RP6JN7SQkHQzZ073O-eYc4h5JTCFQVIrgMWoDFAFgNLIV7tkT5kgsVYYB97wKliKu2RoxCmeGOJ4IekRzPOE5WKPhk-m7Z0s_rDllHh2oV3TYPtwtemCVHdRq3tvAudn1i_-v78enPLaOJcGRlvo6UdHpODCkl7sj0H5PXu9mX0EI-f7h9HN-O4ECpZxEZkUOSSSVGWxlArwVSSSlCFNJRbbrM854LKzKQUUqFUIsBWXBqlitQUwAfkcqM79-69s2GhZ3UobNOY1rou6EQKKSVP1uTFv6RKGOWUMgTPf4FT1_kWf6EZR-syBilCdAMV6ELwttJzX8-MX2kKeh2C3oSgkdfrEPQKd862wl0-s-VuY-s6AmwDBBy16Ozu5b9VfwDfEpG-</recordid><startdate>20090501</startdate><enddate>20090501</enddate><creator>Schöller, K.</creator><creator>Licht, S.</creator><creator>Tonn, J.-C.</creator><creator>Uhl, E.</creator><general>Springer Vienna</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>20090501</creationdate><title>Randomized controlled trials in neurosurgery—how good are we?</title><author>Schöller, K. ; Licht, S. ; Tonn, J.-C. ; Uhl, E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c467t-a490cb5254ddaa1e50af51506c5a13e3e9bb34159a8108466740ef35a66c8ac03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Evidence-Based Medicine</topic><topic>Humans</topic><topic>Interventional Radiology</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Minimally Invasive Surgery</topic><topic>Neurology</topic><topic>Neuroradiology</topic><topic>Neurosurgery</topic><topic>Neurosurgery - methods</topic><topic>Neurosurgical Concepts</topic><topic>Quality Control</topic><topic>Randomized Controlled Trials as Topic - classification</topic><topic>Randomized Controlled Trials as Topic - standards</topic><topic>Research Design</topic><topic>Surgical Orthopedics</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schöller, K.</creatorcontrib><creatorcontrib>Licht, S.</creatorcontrib><creatorcontrib>Tonn, J.-C.</creatorcontrib><creatorcontrib>Uhl, E.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>Acta neurochirurgica</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schöller, K.</au><au>Licht, S.</au><au>Tonn, J.-C.</au><au>Uhl, E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Randomized controlled trials in neurosurgery—how good are we?</atitle><jtitle>Acta neurochirurgica</jtitle><stitle>Acta Neurochir</stitle><addtitle>Acta Neurochir (Wien)</addtitle><date>2009-05-01</date><risdate>2009</risdate><volume>151</volume><issue>5</issue><spage>519</spage><epage>527</epage><pages>519-527</pages><issn>0001-6268</issn><eissn>0942-0940</eissn><abstract>Summary Background The strongest evidence in medical clinical literature is represented by randomized controlled trials (RCTs). This study was designed to evaluate neurosurgically relevant RCTs published recently by neurosurgeons. Method A literature search in MEDLINE and EMBASE included all clinical studies published up to 30 June 2006. RCTs with neurosurgical relevance published by at least one author with affiliation to a neurosurgical department were selected. The number and characteristics of individual trials were recorded, and the quality of the trials with regard to study design, quality of reporting, and relevance for clinical practice was assessed by two different investigators using a modification of the Scottish Intercollegiate Guidelines Network methodology checklist. Changes of RCT quality over time as well as factors influencing the quality were analyzed. Findings From the initial search results (MEDLINE n = 3,860, EMBASE n = 3,113 articles), 159 RCTs published by neurosurgeons were extracted for final evaluation. Of the RCTs, 62% have been published since 1995; 52% came from the USA, UK, and Germany. The median RCT sample size was 78 patients and the median follow-up 35.7 weeks. Fifty-two percent of all RCTs were of good, 37% of moderate, and 11% of bad quality, with an improvement over time. RCTs with financial funding and RCTs with a sample size of &gt;78 patients were of significantly better quality. There were no major differences in the rating of the studies between the two investigators. Conclusions Only a fraction of neurosurgically relevant literature consists of RCTs, but the quality is satisfying and has significantly improved over the last years. An adequate sample size and sufficient financial support seem to be of substantial importance with regard to the quality of the study. Our data also show that by using a standardized checklist, the quality of trials can be reliably assessed by observers of different experience and educational levels.</abstract><cop>Vienna</cop><pub>Springer Vienna</pub><pmid>19337684</pmid><doi>10.1007/s00701-009-0280-y</doi><tpages>9</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0001-6268
ispartof Acta neurochirurgica, 2009-05, Vol.151 (5), p.519-527
issn 0001-6268
0942-0940
language eng
recordid cdi_proquest_miscellaneous_754555370
source MEDLINE; SpringerLink Journals - AutoHoldings
subjects Evidence-Based Medicine
Humans
Interventional Radiology
Medicine
Medicine & Public Health
Minimally Invasive Surgery
Neurology
Neuroradiology
Neurosurgery
Neurosurgery - methods
Neurosurgical Concepts
Quality Control
Randomized Controlled Trials as Topic - classification
Randomized Controlled Trials as Topic - standards
Research Design
Surgical Orthopedics
title Randomized controlled trials in neurosurgery—how good are we?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T17%3A57%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Randomized%20controlled%20trials%20in%20neurosurgery%E2%80%94how%20good%20are%20we?&rft.jtitle=Acta%20neurochirurgica&rft.au=Sch%C3%B6ller,%20K.&rft.date=2009-05-01&rft.volume=151&rft.issue=5&rft.spage=519&rft.epage=527&rft.pages=519-527&rft.issn=0001-6268&rft.eissn=0942-0940&rft_id=info:doi/10.1007/s00701-009-0280-y&rft_dat=%3Cproquest_cross%3E754555370%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=230009208&rft_id=info:pmid/19337684&rfr_iscdi=true